B.C. pharmaceutical company’s stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from around the world with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

Chief executive Peter Greenleaf noted that staff were “thrilled with the outcomes” of the trial and that the drug’s success is significant for people living with lupus – close to 3 million people worldwide. The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

One dead in Balfour house fire

Police are investigating, calling the fire ‘suspicious’

Nelson and COVID-19: everything you need to know

Check this page for every local story related to the outbreak

Canadian police to make home visits to enforce mandatory quarantine for travellers

Police forces have been asked to help verify Canadians are complying with the Quarantine Act

Nelson residents arrive home from quarantine in Peru

Greg Smith, Laurel Conley and Veronica Holman were travelling in Peru before the COVID-19 pandemic

LETTER: Keep smiling and whirling

From reader Allan A. Chalmers

VIDEO: Easter festivities may be scaled back, but it can still be a fun holiday

COVID-19 circumstances have dictated that the holidays may not be perfect

B.C. jails grant early release for close to 100 inmates due to COVID-19

The move, which impacts offenders serving intermittent sentences, is to prevent spread of virus

COVID-19 world update: U.S. to start antibody tests; drones enforce lockdown in Italy

Comprehensive update of coronavirus news from around the world

Lower Mainland hunting store sees 200% increase in firearm sales

Co-owner of Wanstalls says increase due to a variety of reasons

People needing addiction services feeling ‘abandoned’ during pandemic

The province is trying to increase access to addiction care through a phone line of experts, doctors

COVID-19: B.C. ER nurse self-isolates in travel trailer, apart from family

Marcia Kent says situation is difficult but worth it to keep twin boys safe

B.C. unveils $5M for mental health supports during the COVID-19 pandemic

Will include virtual clinics and resources for British Columbians, including front-line workers

B.C.’s COVID-19 rent supplement starts taking applications

$300 to $500 to landlords for April, May and June if eligible

Reality TV show about bodybuilders still filming in Okanagan, amid COVID-19

Five bodybuilders from across the country flew to Kelowna to move into a house for a reality TV show

Most Read